Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001209191-23-027051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-03 | 2023-05-01 | VRTX | MCKENZIE DIANA | Dir | A - Grant | $0.00 | +1,168 | 2,603 | +81% | $0 |
| D | 2023-05-03 | 2023-05-01 | VRTX | MCKENZIE DIANA | Dir | D - Sale to Iss | — | -1,449 | 1,435 | -50% | — |
| D | 2023-05-03 | 2023-05-01 | VRTX | MCKENZIE DIANA | Dir | A - Grant | — | +1,449 | 4,567 | +46% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | A | A | 1,168 | $0.00 | 2,603 | D | — | — | (F2) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| 2 | Common | Common Stock | 2023-05-01 | D | D | 1,449 | — | 1,435 | D | — | — | (F1) Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2022, Ms. McKenzie deferred the receipt of 1,449 shares of common stock and received instead 1,449 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,449 shares of common stock in exchange for an equal number of deferred stock units. |
| 3 | Derivative | Deferred Stock Units | 2023-05-01 | A | A | 1,449 | — | 4,566.52 | D | — · — to — | 1,449 Common Stock | (F1) Upon the vesting of restricted stock units granted to Ms. McKenzie on May 1, 2022, Ms. McKenzie deferred the receipt of 1,449 shares of common stock and received instead 1,449 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. McKenzie is reporting the disposition of 1,449 shares of common stock in exchange for an equal number of deferred stock units. (F3) Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. McKenzie's service on our board of directors, (ii) a change of control of our company and (iii) Ms. McKenzie's disability or death. |